@article{boussemart:hal-02020674,
TITLE = {Tumor mutational burden and response to PD-1 inhibitors in a case series of patients with metastatic desmoplastic melanoma},
AUTHOR = {Boussemart, Lise and Johnson, Adrienne and Schrock, Alexa B and Pal, Sumanta K and Frampton, Garrett M and Fabrizio, David and Chalmers, Zachary and Lotem, Michal and Gibney, Geoffrey and Russell, Jeffery and Chmielowski, Bartosz and Ross, Jeffrey S and Stephens, Philip J and Miller, Vincent A and Ali, Siraj M},
URL = {https://univ-rennes.hal.science/hal-02020674},
JOURNAL = {Journal of The American Academy of Dermatology},
PUBLISHER = {Elsevier},
VOLUME = {80},
NUMBER = {6},
PAGES = {1780-1782},
YEAR = {2019},
MONTH = Jun, DOI = {10.1016/j.jaad.2018.12.020},
KEYWORDS = {pembrolizumab ; hypermutated ; PD-1 ; UV signature ; Desmoplastic melanoma},
PDF = {https://univ-rennes.hal.science/hal-02020674/file/Tumor%20mutational%20burden%20and%20response%20to%20PD-1%20inhibitors.pdf},
HAL_ID = {hal-02020674},
HAL_VERSION = {v1},
}